United States
Germany
Japan
United Kingdom
China
Products
KRAS Rabbit polyclonal Antibody
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Unmodified |
热销推荐
KRAS mouse monoclonal antibody, clone OTI6A6 (formerly 6A6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Phospho-KRAS-S89 Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho S89 |
KRAS mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI8B4 (formerly 8B4)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI2F8 (formerly 2F8)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI3B12 (formerly 3B12)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI4B3 (formerly 4B3)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI4F6 (formerly 4F6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI4C6 (formerly 4C6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (57)
- Axon guidance (57)
- B cell receptor signaling pathway (57)
- Bladder cancer (57)
- Chemokine signaling pathway (57)
- Chronic myeloid leukemia (57)
- Colorectal cancer (57)
- Dorso-ventral axis formation (57)
- Endometrial cancer (57)
- ErbB signaling pathway (57)
- Fc epsilon RI signaling pathway (57)
- Gap junction (57)
- Glioma (57)
- GnRH signaling pathway (57)
- Insulin signaling pathway (57)
- Long-term depression (57)
- Long-term potentiation (57)
- MAPK signaling pathway (57)
- Melanogenesis (57)
- Melanoma (57)
- Natural killer cell mediated cytotoxicity (57)
- Neurotrophin signaling pathway (57)
- Non-small cell lung cancer (57)
- Pancreatic cancer (57)
- Pathways in cancer (57)
- Progesterone-mediated oocyte maturation (57)
- Prostate cancer (57)
- Regulation of actin cytoskeleton (57)
- Renal cell carcinoma (57)
- T cell receptor signaling pathway (57)
- Thyroid cancer (57)
- Tight junction (57)
- VEGF signaling pathway (57)
